A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas-Reference-Cited by-全球学者库

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Published:2016-08-08 Issue:1 Volume:4 Page:
ISSN:2051-5960
Container-title:Acta Neuropathologica Communications
language:en
Short-container-title:acta neuropathol commun

Author:

Arita Hideyuki,Yamasaki Kai,Matsushita Yuko,Nakamura Taishi,Shimokawa Asanao,Takami Hirokazu,Tanaka Shota,Mukasa Akitake,Shirahata Mitsuaki,Shimizu Saki,Suzuki Kaori,Saito Kuniaki,Kobayashi Keiichi,Higuchi Fumi,Uzuka Takeo,Otani Ryohei,Tamura Kaoru,Sumita Kazutaka,Ohno Makoto,Miyakita Yasuji,Kagawa Naoki,Hashimoto Naoya,Hatae Ryusuke,Yoshimoto Koji,Shinojima Naoki,Nakamura Hideo,Kanemura Yonehiro,Okita Yoshiko,Kinoshita Manabu,Ishibashi Kenichi,Shofuda Tomoko,Kodama Yoshinori,Mori Kanji,Tomogane Yusuke,Fukai Junya,Fujita Koji,Terakawa Yuzo,Tsuyuguchi Naohiro,Moriuchi Shusuke,Nonaka Masahiro,Suzuki Hiroyoshi,Shibuya Makoto,Maehara Taketoshi,Saito Nobuhito,Nagane Motoo,Kawahara Nobutaka,Ueki Keisuke,Yoshimine Toshiki,Miyaoka Etsuo,Nishikawa Ryo,Komori Takashi,Narita Yoshitaka,Ichimura Koichi

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40478-016-0351-2

Reference36 articles.

1. Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, Ichimura K. Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss. Acta Neuropathol. 2013;126:267–76.

2. Arita H, Narita Y, Matsushita Y, Fukushima S, Yoshida A, Takami H, Miyakita Y, Ohno M, Shibui S, Ichimura K. Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomas. Brain Tumor Pathol. 2015;32:22–30.

3. Bell RJ, Rube HT, Kreig A, Mancini A, Fouse SD, Nagarajan RP, Choi S, Hong C, He D, Pekmezci M, Wiencke JK, Wrensch MR, Chang SM, Walsh KM, Myong S, Song JS, Costello JF. Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. Science. 2015;348:1036–9.

4. Bettegowda C, Agrawal N, Jiao Y, Sausen M, Wood LD, Hruban RH, Rodriguez FJ, Cahill DP, McLendon R, Riggins G, Velculescu VE, Oba-Shinjo SM, Marie SK, Vogelstein B, Bigner D, Yan H, Papadopoulos N, Kinzler KW. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science. 2011;333:1453–5.

5. Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA, Morozova O, Newton Y, Radenbaugh A, Pagnotta SM, Anjum S, Wang J, Manyam G, Zoppoli P, Ling S, Rao AA, Grifford M, Cherniack AD, Zhang H, Poisson L, Carlotti Jr CG, Tirapelli DP, Rao A, Mikkelsen T, Lau CC, Yung WK, Rabadan R, Huse J, Brat DJ, Lehman NL, Barnholtz-Sloan JS, Zheng S, Hess K, Rao G, Meyerson M, Beroukhim R, Cooper L, Akbani R, Wrensch M, Haussler D, Aldape KD, Laird PW, Gutmann DH, Network TR, Noushmehr H, Iavarone A, Verhaak RG. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164:550–63.

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The -124C>T mutation of TERT promoter indicated a favorable prognosis in OCCC: a monoinstitutional study in China;2024-02-02

2. The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target?;Cells;2023-12-25

3. Association of MGMT Promoter and Enhancer Methylation with Genetic Variants, Clinical Parameters, and Demographic Characteristics in Glioblastoma;Cancers;2023-12-09

4. Comprehensive clinical assays for molecular diagnostics of gliomas: the current state and future prospects;Frontiers in Molecular Biosciences;2023-10-16

5. Machine learning models based on multi-parameter MRI radiomics for prediction of molecular glioblastoma: a new study based on the 2021 World Health Organization classification;Acta Radiologica;2023-09-21